One diagnosis, two perspectives: A Signatera™ HNSCC story

Upcoming webinar

One diagnosis, two perspectives:

A Signatera™ HNSCC story

Date: Monday, September 21, 2026

Time: 4:30 PM PT | 7:30 PM ET (60-minute webinar)

Registrants will receive a recording of the webinar approximately one week after the event.

Dr. James Duke is not a typical physician you will hear from in our webinars. As a retired orthopedic surgeon and an oral squamous cell carcinoma survivor, he brings a rare combination of clinical literacy and lived experience that few patients can offer. Join Dr. Duke and his treating physician, University of Florida Health head and neck surgical oncologist, Dr. Peter Dziegielewski, for a candid and clinically rigorous conversation on Signatera™ MRD testing. This patient and treating physician team will discuss Dr. Duke’s journey through diagnosis, post-treatment surveillance, and what personalized monitoring means for life beyond cancer.

The discussion will cover how Signatera™ MRD testing:

Integrates into the HNSCC treatment journey, from surgical planning through post-treatment surveillance
Informs real clinical decisions and shapes how physicians monitor for recurrence
Supports long-term patient outcomes and confidence in survivorship

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers:

Peter Dziegielewski, MD, FRCSC, FACS

Head and Neck Surgical Oncologist

University of Florida Health

James Duke, MD

Retired Orthopedic Surgeon

Oral squamous cell carcinoma survivor

Signatera™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy